Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
Clinical trial NCT02658435 · COMPLETED
Trial details
- NCT number
- NCT02658435
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-02
- Primary completion
- 2017-09-14
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.